Pyoderma gangrenosum: Case series;Pioderma gangrenoso: Presentazione di alcuni casi clinici

Clinica Terapeutica

Volumn 158, Issue 4, 2007, Pages 325-329

  Richetta, Antonio Giovanni ^a,b   Maiani, E ^a   Carboni, V ^a   Carlomagno, V ^a   Cimillo, M ^a   Mattozzi, C ^a   Calvieri, S ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

Author keywords

Biologic therapy; Inflammatory bowel diseases; Pyoderma gangrenosum

Indexed keywords

ANTIBIOTIC AGENT; CORTICOSTEROID; CYCLOSPORIN; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; INFLIXIMAB; MESALAZINE; PREDNISONE; TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; ENTERITIS; FEMALE; HUMAN; MALE; PYODERMA GANGRENOSUM; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ADULT; DERMATOLOGIC AGENTS; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; PYODERMA GANGRENOSUM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34547615370     PISSN: 00099074     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Brunsting LA, Goeckerman WH, O'Leory PA. Pyoderma (ecthyma) gangrenosum: clinical and expermental observations in five cases occurring in adults. Arch Dermatol 1930; 22:655-80
2. Conrad C, Trueb RM. Pyoderma Gangrenosum. J Dtsch Dermatol Ges 2005; 3(5):334-42
3. Zhang Xi-bao, HE Yu-qing, Zhou Hua, et al. A case of pyoderma gangrenosum responding to high-dose intravenous immunoglobulin therapy. Chin Med J 2006; 119(14):1230-2
4. Von den Driesch P. Pyoderma gangrenosum: a report of 44 cases with follow-up. Br J Dermatol 1997; 337:1000-5
5. Callen JP. Pyoderma gangrenosum and related disorders. Med Clin North Am 1989; 73:1247-61
6. Braun-Falco O. Dermatology. Berlin, Springer-Verlag, 2000
7. Brooklyn T, Dunnill G, Probert C. Diagnosis and treatment of pyoderma gangrenosum. BMJ 2006; 333(7560):181-4
8. Kouklakis G, Moschos J, Leontiadis GI, et al. Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report. Romanian J Gastroenterol 2005; 14(4):401-3
9. Piccirillo A, Ricciuti F. Topical tacrolimus for pyoderma gangrenosum: another report. J Dermatol 2006; 33(3):232
10. Chiba T, Isomura I, Suzuki A, et al. Topical tacrolimus therapy for pyoderma gangrenosum. J Dermatol 2006; 32(3):199-203
11. Petering H, Kiehl P, Breuer C, et al. Pyoderma gangrenosum: successful topical therapy with tacrolimus (FK506). Hautarzt 2001; 52(1):47-50
12. Zhang XB, He YQ, Zhou H, et al. A case of pyoderma gangrenosum responding to high-dose intra venousimmunoglobulin therapy. Chin Med J(Engl) 2006; 119(14):1230-2
13. Jolles S, Hughes J. Use of IGIV in the treatment of atopic dermatitis, urticaria, scleromyxedema, pyoderma gangrenosum, psoriasis, and pretibial myxedema. Int Immunopharmacol 2006; 6(4):579-91. EPUB 2005 Dec 13. Review
14. Roy DB, Conte ET, Cohen DJ. The treatment of pyoderma gangrenosum using etanercept. J Am Acad Dermatol 2006; 54(3 Suppl 2):S128-34
15. Fonder MA, Cummins DL, Ehst BD, et al. Adalimumab therapy for recalcitrant pyoderma gangrenosum. J Burns and Wounds 2006; 5:66-71
16. Callen JP. Pyoderma gangrenosum. Lancet 1998; 351:581-5
17. Regueiro M, Valentine J, Plevy S, et al. Infliximab for treatment of Pyoderma gangrenosum associated with inflammatory bowel disease. Am J Gastroenterol 2003; 98:1821-6
18. Targan SR, Hanauer SB, van Deventer SJ, et al. A short term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease CA2 Study Group. N Engl J Med 1997; 337:1029-35
19. Present DH, Rutgeers P, Targan S, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999; 340:1398-405
20. Zaccagna A, Bertone A, Puiatti P, et al. Anti-tumor necrosis factor alpha monoclonal antibody (infliximab) for the treatment of pyoderma gangrenosum associated with Crohn's disease. Eur J Dermatol 2003; 13:258-60
21. Hong JJ, Merel NH, Hanauer SB. Treatment of Pyoderma gangrenosum complicating Crohn's disease with Infliximab. Gastroenterology 2001; 120(Suppl 1):P. A-621
22. Botros N, Pickover L, Das KM. Image of the Month. Pyoderma gangrenosum caused by ulcerative colitis. Gastroenterology 2000; 118:654-809
23. Ardizzone S, Bollani S, Colombo E, et al. Infliximab for the treatment of Pyoderma gangrenosum in steroid dependent ulcerative colitis. Gut 2001; 49(Suppl 3):Abstr 3190
24. Triantafillidis JK, Cheracakis P, Sklavaina M, et al. Favorable response to Infliximab treatment in a patient with active Crohn disease and Pyoderma gangrenosum. Scand J Gastroenterol 2002; 37:863-5